As an example, in triple adverse breast cancer (TNBC),25 and in hepatocellular carcinoma,26 DNA methylation profiles have assisted to your identification of distinct subgroups with clinical relevance. Epigenetic approaches have also aided to the development of prognostic exams to assess the sensitivity of cancer cells to specific drugs.27 Implementing https://directivepublications.org/world-journal-of-clinical-cancer-research/